Allergy PBMC
About: Allergy PBMC samples are collected from clinically confirmed allergy donors and cryopreserved for downstream immunology and dermatological research. Ideal for studying inflammatory pathways, immune cell responses, and therapeutic development in allergies.
| Lot # | Condition | Cell Count (M) | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 74801 | Allergy | 10M | Caucasian | 61 | Female | United States |
Current: cellcept mycophenolate 2500mg QD nifedipine 30mg QD Multivitamin Previous: omeprazole 20 mg
|
4 | $530.00 | |
| 73077 | Allergy | 35M | African American | 31 | Female |
Lexapro, Wellbutrin, Amlodipine, Rosuvastatin
|
1 | |||
| 74244 | Allergy | 40M | African American | 31 | Female |
Lexapro QD Wellbutrin QD Amlodipine QD Rosuvastatin QD
|
1 | |||
| 73321 | Allergy | 10M | African American | 60 | Male |
Opzelura - taking since Feb 2025 Flonase, 50mg, 2 sprays per nostril QD Lipitor, 80mg, QD children's aspirin, QD Coreg, 12.5mg, BID Norvasc, 10mg, QD alopurinol 100 mg QD Phototherapy
|
1 | $530.00 | ||
| 72769 | Allergy | 10M | African American | 60 | Male |
Opzelura - taking since Feb 2025 Flonase, 50mg, 2 sprays per nostril QD Lipitor, 80mg, QD children's aspirin, QD Coreg, 12.5mg, BID Norvasc, 10mg, QD alopurinol 100 mg QD Phototherapy
|
5 | $530.00 | ||
| 63717 | Allergy | 10M | Hispanic/Latino | 53 | Female |
Albuterol Inhaler PRN
|
2 | $530.00 | ||
| 58264 | Allergy | 100M | African American Hispanic/Latino | 36 | Male | 39 | ||||
| 55416 | Allergy | 10M | Hispanic/Latino | 35 | Male |
No medications
|
1 | $530.00 | ||
| 56170 | Allergy | 10M | African American | 50 | Female |
Truvada -Prep/ QD
|
1 | $530.00 | ||
| 58304 | Allergy | 5M | Caucasian | 79 | Female | 1 | $530.00 |
High-Quality Allergy PBMCs for Research
Allergy PBMC products are sourced from donors clinically diagnosed with allergy and processed under stringent conditions to support research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies on immune dysregulation, cytokine response, and therapeutic screening for allergy-related inflammation.
Product Features
- Research Use Only (RUO), cryopreserved Peripheral Blood Mononuclear Cells
- Clinically confirmed allergy donors
- Available in cell counts ranging from 5 million to 2 billion
- Processed within 24 hours of collection
- Stored using CryoStor® CS10 freezing media
- IRB-approved protocols and electronic informed consent
- Screen LeukoLot™ available prior to bulk orders
De-identified Donor Data
- Verified allergy diagnosis
- Donor demographics: age, sex assigned at birth, race/ethnicity
- Self-reported allergies and infectious disease history
- Additional allergy-specific data available upon request
Applications
- Biomarker discovery and validation
- Drug screening and therapeutic development
- Immune pathway analysis in Allergy pathophysiology
- Transcriptomic and proteomic profiling
Quality and Compliance
- IRB-approved collections and protocols
- 21 CFR Part 11 – compliant e-consent system
- HIPAA-compliant donor data protection
Ordering & Shipping
Allergy PBMC samples are shipped on dry ice and available in custom aliquots. For international orders or regulatory requirements, please contact learnmore@sanguinebio.com to confirm documentation and compliance needs.
Protocols & Documentation
-
Download
PBMC Isolation from Whole Blood
Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.
-
Download
Immune Cell Isolation
Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.
-
Download
Choosing the Right PBMC Configuration
Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.
-
Download
Thawing Cryopreserved PBMC
Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Allergy Publications
PBMC
Frequently Asked Questions
1 Answer
Electronic medical records are an option to be included with the PBMC sample, as well as, flow cytometry and other phenotypic testing.
1 Answer
YES – we can often accommodate treatment-naive samples including various cancers, and you can specify immunosupression status or other requirements in the I/E criteria.
1 Answer
Self-reported infectious disease testing is always available and some of our products have additional testing.
1 Answer
HLA-typing is available for some of our PBMC products.
1 Answer
YES to both – Unique donors can be specified, and multiple vials from the same donor can be arranged. You can specify these requirements when ordering.
1 Answer
Healthy PBMCs achieve over 90% vialbity post-thaw. Although our disease-state PBMCs are processed with same stringent SOP, there is more variability depending upon disease. Learn more about our post thaw viability here. https://sanguinebio.com/pbmc-viability-quality-assurance/
Ask a Question
Need a custom PBMC cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.